Fox Chase Cancer Center

Adjuvant durvalumab significantly improved PFS and OS compared with placebo among patients with limited-stage small cell lung cancer, according to study results presented at ESMO Congress.

Five-fraction stereotactic body radiotherapy proved noninferior to conventional radiotherapy with regard to biochemical or clinical failure for men with localized prostate cancer, according to randomized phase 3 study results.

Nivolumab plus chemotherapy significantly extended PFS for children and adults with newly diagnosed advanced Hodgkin lymphoma compared with standard of care, according to results of a randomized phase 3 trial.

Sanjay S. Reddy, MD, FACS, has been appointed division chief of surgical oncology at Fox Chase Cancer Center.

The Leukemia & Lymphoma Society awarded a research team at Fox Chase Cancer Center a nearly $2.4 million grant to improve clinical trial access for patients, particularly those from underrepresented groups, across the Temple Health system.

Incorporating palliative care into a hematology/oncology fellowship improve fellows’ knowledge and confidence providing these services, according to research presented at ASCO Annual Meeting.

Jeffrey M. Farma, MD, FACS, has been appointed chair of surgery at Fox Chase Cancer Center.

Researchers at Montefiore Einstein Comprehensive Cancer Center have developed an AI-based patient navigation tool that may increase completion of colonoscopies among individuals who canceled or did not show for an initial appointment.

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

Michael J. Hall, MD, MS, FASCO, must occasionally remind himself not everyone holds genetics research in the high esteem he does.